Olon SpA is a global leader in the development and production of Active Pharmaceutical Ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and microbial biomanufacturing. The company operates 14 GMP facilities primarily in Italy, with additional sites in France (via GTP Bioways acquisition), the US, Germany, and China, with 450+ DMFs and 35+ years of regulatory experience.
API chemical synthesis, microbial biomanufacturing, high-potency API manufacturing, ADC manufacturing, peptide and protein manufacturing, fermentation
7 sites worldwide
No reviews available yet.
No documents available.